Pre-earnings options volume in Ocular Therapeutix is normal with puts leading calls 3:2. Implied volatility suggests the market is anticipating a move near 11.5%, or $1.13, after results are released. Median move over the past eight quarters is 4.1%.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OCUL:
- Options Volatility and Implied Earnings Moves Today, March 11, 2024
- Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
- Ocular Therapeutix Inc (OCUL) Q4 Earnings Cheat Sheet
- Ocular Therapeutix options imply 8.8% move in share price post-earnings
- Ocular Therapeutix price target raised to $15 from $10 at Piper Sandler